Research in earlier phases or small trials include evaluation of GLP-1s for indications such as cystic fibrosis-related diabetes, polycystic ovarian syndrome (PCOS), chronic obstructive pulmonary disease (COPD), Prader-Willi syndrome (PWS), asthma, substance or alcohol use disorder, and as add-on to insulin for type 1 diabetes
There is a meaningful gap between GLP-1 research, fasting research, and combined research
The specific products matter less than the total carbohydrate intake and the fact that you have tested everything in training
References Lewis JJ, Brennan MF
Similar to Clover, Alignment saw solid membership growth during open enrollment
Comparing 10mg vials to other tirzepatide vial sizes The 10mg vial is one of several sizes available for compounded tirzepatide